HyPEing the Human Genome
Submitted by ETC Staff on
A new report by ETC Group argues that the pharmaceutical industry's major interest in "The Book of Life" and parallel advances in neurosciences lies in the development of new drugs and therapies that target "well people" rather than the ill. The study also shows that company strategies focusing on parents could eliminate the "different" in the human species in favour of a monocultural "norm." In addition, industry and government are exploring the potential to use the new genomics to monitor and control dissent.